Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexmedetomidine in high-risk on-pump cardiac surgery
ACTRN12615001358538Phase 2Completed
- Sponsor
- Monash Medical Centre
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in coronary arteriosclerosis, Cardiac valve disease (VHD) and Aortic Arch Disease comparing Dexmedetomidine + standard anaesthesia with Placebo/standard anaesthesia control (2 arms). Primary endpoint: Days home, alive and disability-free at 28 days. Started Feb 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosisCardiac valve disease (VHD)Aortic Arch Disease
Beyond the preview
Go deeper on ACTRN12615001358538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001358538.